...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Development and Validation of an Instrument for Measuring Attitudes and Beliefs about Complementary and Alternative Medicine (CAM) Use among Cancer Patients
【24h】

Development and Validation of an Instrument for Measuring Attitudes and Beliefs about Complementary and Alternative Medicine (CAM) Use among Cancer Patients

机译:癌症患者中辅助和替代医学(CAM)使用态度和信念的测量工具的开发和验证

获取原文

摘要

Despite cancer patients' extensive use of complementary and alternative medicine (CAM), validated instruments to measure attitudes, and beliefs predictive of CAM use are lacking. We aimed at developing and validating an instrument, attitudes and beliefs about CAM (ABCAM). The 15-item instrument was developed using the theory of planned behavior (TPB) as a framework. The literature review, qualitative interviews, expert content review, and cognitive interviews were used to develop the instrument, which was then administered to 317 outpatient oncology patients. The ABCAM was best represented as a 3-factor structure: expected benefits, perceived barriers, and subjective norms related to CAM use by cancer patients. These domains had Eigenvalues of 4.79, 2.37, and 1.43, and together explained over 57.2% of the variance. The 4-item expected benefits, 7-item perceived barriers, and 4-item subjective norms domain scores, each had an acceptable internal consistency (Cronbach's alpha) of 0.91, 0.76, and 0.75, respectively. As expected, CAM users had higher expected benefits, lower perceived barriers, and more positive subjective norms (allP<0.001) than those who did not use CAM. Our study provides the initial evidence that the ABCAM instrument produced reliable and valid scores that measured attitudes and beliefs related to CAM use among cancer patients.
机译:尽管癌症患者广泛使用补充和替代药物(CAM),但仍缺乏用于衡量态度的有效手段和预测CAM使用的信念。我们旨在开发和验证关于CAM(ABCAM)的工具,态度和信念。使用计划行为理论(TPB)作为框架,开发了15个项目的工具。使用文献复习,定性访谈,专家内容复习和认知访谈来开发该仪器,然后将其应用于317名门诊肿瘤患者。 ABCAM最好用三因素结构表示:预期收益,可感知的障碍以及与癌症患者使用CAM相关的主观规范。这些域的特征值分别为4.79、2.37和1.43,共同解释了超过57.2%的方差。 4个项目的预期收益,7个项目的感知障碍和4个项目的主观规范领域得分,各自具有可接受的内部一致性(克朗巴赫α),分别为0.91、0.76和0.75。正如预期的那样,与不使用CAM的用户相比,使用CAM的用户具有更高的预期收益,更低的感知障碍和更积极的主观规范(allP <0.001)。我们的研究提供了初步的证据,证明ABCAM仪器产生了可靠且有效的分数,可以衡量癌症患者中与CAM使用相关的态度和信念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号